Tumor-infiltrating CD39+CD8+ T cells determine poor prognosis and immune evasion in clear cell renal cell carcinoma patients-Reference-Cited by-同舟云学术

Tumor-infiltrating CD39+CD8+ T cells determine poor prognosis and immune evasion in clear cell renal cell carcinoma patients

Published:2020-04-18 Issue:8 Volume:69 Page:1565-1576
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Qi Yu,Xia Yu,Lin Zhiyuan,Qu Yang,Qi Yangyang,Chen Yifan,Zhou Quan,Zeng Han,Wang Jiajun,Chang Yuan,Bai Qi,Wang Yiwei,Zhu Yu,Xu Le,Chen Lingli,Kong Yunyi,Zhang Weijuan,Dai Bo,Liu Li,Guo Jianming,Xu Jiejie^ORCID

Funder

National Natural Science Foundation of China

Shanghai Municipal Population and Family Planning Commission

National Key R&D Program of China

Shanghai Municipal Natural Science Foundation

Guide Project of Science and Technology Commission of Shanghai Municipality

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

https://link.springer.com/content/pdf/10.1007/s00262-020-02563-2.pdf

Reference31 articles.

1. Bray F, Ferlay J, Soerjomataram I et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394–424

2. Schodel J, Grampp S, Maher ER et al (2016) Hypoxia, hypoxia-inducible transcription factors, and renal cancer. Eur Urol 69(4):646–657

3. Cohen HT, Mcgovern FJ (2005) Renal-cell carcinoma. N Engl J Med 353:2477–2490

4. Scherr AJ, Lima JPS, Sasse EC, Lima CS, Sasse AD (2011) Adjuvant therapy for locally advanced renal cell cancer: a systematic review with meta-analysis. BMC Cancer 11(1):115

5. Gupta K, Miller JD, Li JZ et al (2008) Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): a literature review. Cancer Treat Rev 34(3):193–205

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. APOBEC3C‐mediated NF‐κB activation enhances clear cell renal cell carcinoma progression;Molecular Oncology;2024-08-26

2. CD39 transforming cancer therapy by modulating tumor microenvironment;Cancer Letters;2024-08

3. PD1/PD-L1 blockade in clear cell renal cell carcinoma: mechanistic insights, clinical efficacy, and future perspectives;Molecular Cancer;2024-07-16

4. Characteristics of mast cell infiltration in lung adenocarcinoma and its impact on prognosis;Discover Oncology;2024-06-04

5. Identification of clinically relevant subsets CD39+PD-1+CD8+ T cells and CD39+ regulatory T cells in intrahepatic cholangiocarcinoma using single-cell CyTOF;Translational Oncology;2024-06